Favism: Clinical Features at Different Ages.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
10 Jan 2023
Historique:
received: 06 12 2022
revised: 28 12 2022
accepted: 05 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Favism is a hemolytic disease due to the ingestion of fava beans in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. There is wide inter- and intra-individual variability in the development of hemolytic crisis, and several factors influence it: quantity, quality, ripeness of fava beans, and age of onset. In this narrative review of case reports and case series, we reported the predisposing factors and clinical features for four different age groups classified as follows: pregnant women and infants (i.e., exclusively breastfed children); children, from weaned to 11 years; preadolescents and adolescents, from 11 to 18 years; and adults (18 years and older). Some symptoms developed only in specific age groups: death in infants; visual impairment in children; systolic murmur in infants, children, and adolescents; and renal failure in adults. In youngest children or pregnant women the severity is the highest. Some other symptoms were present in all: jaundice, increased bilirubin, splenomegaly, hepatomegaly, discolored urine, tachycardia, pallor, abdominal pain, malaise, vomit, nausea, and dizziness. Laboratory findings are characterized by anemia, reticulocytosis, elevated bilirubin level, and sometimes urinary urobilinogen and methemoglobinemia. In most cases the symptomatology is self-limited and does not release sequelae, but hospitalization and transfusion are often required.

Identifiants

pubmed: 36678214
pii: nu15020343
doi: 10.3390/nu15020343
pmc: PMC9864644
pii:
doi:

Substances chimiques

Bilirubin RFM9X3LJ49

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Am Med Assoc. 1959 Sep 19;171:299-300
pubmed: 14400102
West J Med. 1989 Oct;151(4):459-60
pubmed: 2588584
J Pediatr. 1975 Apr;86(4):565-7
pubmed: 1127504
Ann Ist Super Sanita. 1999;35(2):193-203
pubmed: 10645652
Blood. 2013 Oct 24;122(17):2933
pubmed: 24312948
Lancet. 1955 Apr 9;268(6867):748-9
pubmed: 14368862
J Pediatr. 1995 Nov;127(5):807-8
pubmed: 7472841
Bull World Health Organ. 1989;67(6):601-11
pubmed: 2633878
Medicine (Baltimore). 2021 Nov 24;100(47):e27904
pubmed: 34964759
J Pediatr. 1957 Oct;51(4):445-7
pubmed: 13476327
Arch Dis Child. 1965 Jun;40:271-3
pubmed: 14294749
J Am Diet Assoc. 1997 Feb;97(2):182-3
pubmed: 9020249
Arch Dis Child. 1953 Oct;28(141):369-71
pubmed: 13105385
Semin Hematol. 1990 Jan;27(1):1-40
pubmed: 2405494
Eur J Biochem. 1982 Oct;127(2):405-9
pubmed: 7140776
Br Med J. 1956 May 5;1(4974):1023
pubmed: 13304416
Yale J Biol Med. 1951 Sep;24(1):5-8
pubmed: 14884561
N Engl J Med. 1947 Jun 26;236(26):974-7
pubmed: 20248434
JAMA. 1962 Apr 14;180:119-21
pubmed: 13875561
Arch Dis Child. 1971 Feb;46(245):121-3
pubmed: 5555486
Am J Clin Pathol. 1956 Jan;26(1):42-7
pubmed: 13292383
Lancet. 1985 Nov 2;2(8462):1013
pubmed: 2865483
Hematol Oncol Clin North Am. 2016 Apr;30(2):373-93
pubmed: 27040960
N Engl J Med. 1948 Sep 2;239(10):367
pubmed: 18879460
Can Med Assoc J. 1966 Feb 5;94(6):292-4
pubmed: 5903167
Hong Kong Med J. 2006 Apr;12(2):149-51
pubmed: 16603783
Rev Chil Pediatr. 2014 Feb;85(1):74-9
pubmed: 25079187
Acta Med Port. 2000 Jul-Aug;13(4):237-40
pubmed: 11155491
Hum Exp Toxicol. 2011 Apr;30(4):335-7
pubmed: 20930025
Clin Case Rep. 2021 Feb 20;9(4):2048-2052
pubmed: 33936638
Br Med J. 1955 Jan 15;1(4906):149-50
pubmed: 13219366
J Pediatr. 1953 Apr;42(4):453-6
pubmed: 13053334
J Clin Pathol. 2005 Mar;58(3):317-9
pubmed: 15735168
Int J Hematol. 2011 May;93(5):664-666
pubmed: 21479984
Br J Ophthalmol. 1960 Jun;44:353-6
pubmed: 13810004
Am J Emerg Med. 1993 Sep;11(5):560-1
pubmed: 8363691
Hosp Pediatr. 2016 Sep;6(9):560-5
pubmed: 27554269
Med J Aust. 1958 Oct 4;2(14):455-8
pubmed: 13589360
Pediatr Hematol Oncol. 2014 Feb;31(1):104-6
pubmed: 23697341
BMJ. 1990 Jan 27;300(6719):236
pubmed: 2106932
Lancet. 1960 Mar 19;1(7125):628-9
pubmed: 13828644
Rev Med Chil. 2012 Aug;140(8):1043-5
pubmed: 23282778
J Pediatr. 1961 Feb;58:263-6
pubmed: 13726584
Ital J Pediatr. 2014 Jul 21;40:71
pubmed: 25048415

Auteurs

Alice Beretta (A)

Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Via Bassi 21, 27100 Pavia, Italy.

Matteo Manuelli (M)

Clinical Nutrition and Dietetics Service, Unit of Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Hellas Cena (H)

Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Via Bassi 21, 27100 Pavia, Italy.
Clinical Nutrition and Dietetics Service, Unit of Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH